Company / Working Capital per Share
NEKTAR THERAPEUTICS Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$17.18
FY2025
5-year range
$1.04 / $17.18
FY2021-FY2025
Trend
+1544.5%
vs FY2024
Sector context
#23 of 210
Health Care
What the data says
Working Capital per Share changed +1545% YoY in FY2025, a notable deviation from the 9-year average annual change of +191%.
Based on SEC 10-K filings.
17.18 in FY2025 with a 5-year CAGR of +24.3%. Top quartile in the Health Care sector.
Improved from $1.48 to $17.18 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +88.2%
- 5-Year CAGR
- +24.3%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 210This company $17.18 Sector average $118.60
▼
-85.5% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 1544.5% year-over-year.
- Ranks #23 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.18 | +1544.5% |
| FY2024 | $1.04 | -29.5% |
| FY2023 | $1.48 | -42.5% |
| FY2022 | $2.58 | -34.7% |
| FY2021 | $3.94 | -31.9% |
| FY2020 | $5.79 | -5.9% |
| FY2019 | $6.15 | -27.6% |
| FY2018 | $8.50 | +381.1% |
| FY2017 | $1.77 | -32.5% |
| FY2016 | $2.62 | +18.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026